AbCellera Biologics Inc.

ABCLNASDAQHealthcareBiotechnology

$11.80- (-)1Y +126.83%

As of Oct 16, 2026 close

Market cap: $3.87B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $2.75$15.02
Volume (live): -
Avg. volume (3M): 5.02M

AbCellera Biologics Inc. (ABCL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for AbCellera Biologics Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(12 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$16.63

+40.93% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest ABCL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 29, 2026	Brian Cheng	JP Morgan	Initiates	Buy	$17.00
Sep 27, 2026	Debanjana Chatterjee	JonesTrading	Reiterates	Buy	$13.00 → $25.00 +12.00 (+92.3%)
Sep 24, 2026	Andrea Newkirk	Goldman Sachs	Initiates	Hold	$13.00
Sep 2, 2026	Srikripa Devarakonda	Truist	Reiterates	Buy	$30.00
Aug 18, 2026	Evan Seigerman	BMO Capital	Maintains	Buy	$15.00
Aug 17, 2026	Evan Seigerman	BMO Capital	Maintains	Buy	$15.00
Aug 14, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Aug 7, 2026	Allison Bratzel	Piper Sandler	Maintains	Buy	$12.00
Aug 6, 2026	Stephen Willey	Stifel Nicolaus	Maintains	Buy	$8.00 → $9.00 +1.00 (+12.5%)
Aug 6, 2026	Steven Seedhouse	Cantor Fitzgerald	Reiterates	Buy	$11.00 → $12.00 +1.00 (+9.1%)
Aug 5, 2026	Steven Seedhouse	Cantor Fitzgerald	Reiterates	Buy	$11.00 → $12.00 +1.00 (+9.1%)
Aug 5, 2026	Brendan Smith	TD Cowen	Maintains	Buy	-

Brian Cheng

JP Morgan

BuyInitiates

$17.00

Sep 29

Debanjana Chatterjee

JonesTrading

BuyReiterates

$13.00 → $25.00

Sep 27

Andrea Newkirk

Goldman Sachs

HoldInitiates

$13.00

Sep 24

Srikripa Devarakonda

Truist

BuyReiterates

$30.00

Sep 2

Evan Seigerman

BMO Capital

BuyMaintains

$15.00

Aug 18

Evan Seigerman

BMO Capital

BuyMaintains

$15.00

Aug 17

Zacks Equity Research

BuyInitiates Coverage

Aug 14

Allison Bratzel

Piper Sandler

BuyMaintains

$12.00

Aug 7

Stephen Willey

Stifel Nicolaus

BuyMaintains

$8.00 → $9.00

Aug 6

Steven Seedhouse

Cantor Fitzgerald

BuyReiterates

$11.00 → $12.00

Aug 6

Steven Seedhouse

Cantor Fitzgerald

BuyReiterates

$11.00 → $12.00

Aug 5

Brendan Smith

TD Cowen

BuyMaintains

Aug 5

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 29, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ABCL?

The analyst consensus rating for ABCL is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for ABCL?

The average 12-month price target for ABCL is $16.63, representing an upside of 40.9% from the Oct 16, 2026 close of $11.80.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.